OnKure Therapeutics, Inc.
OKUR
$2.47
-$0.06-2.37%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -84.47% | -72.79% | -9.87% | ||
| Total Depreciation and Amortization | 66.40% | -4.52% | 17.97% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 2,553.92% | 9,972.22% | 664.29% | ||
| Change in Net Operating Assets | -500.41% | 285.01% | -133.91% | ||
| Cash from Operations | -232.68% | 41.65% | -133.45% | ||
| Capital Expenditure | 54.55% | 83.33% | 18.18% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | 48,312.12% | 83.33% | 18.18% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 654,144.44% | 66.67% | -75.61% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 5,136,300.00% | -1,675.00% | -- | ||
| Cash from Financing | 1,102,360.00% | 293,500.00% | -99.98% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 1,559.63% | 94.49% | -121.89% | ||